Dr. Andrei R Shustov MD
Hematologist-Oncologist | Hematology & Oncology
825 Eastlake Avenue E G3-200 Seattle WA, 98109About
Dr. Andrei Shustov is a hematologist oncologist practicing in Seattle, WA. Dr. Shustov specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Crimean State Medical Institute 1993
Crimean State Medical University named after S.I. Georgievskiy
Crimea Medical Institute in Ukraine 1993
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- T-cell lymphoma: one name with a dozen faces.
- Evidence-based guidelines--an introduction.
- Does high-dose therapy and autologous hematopoietic stem cell transplantation have a role in the primary treatment of peripheral T-cell lymphomas? ASH evidence-based review 2008.
- Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.
- Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study.
- Extranodal natural killer T-cell lymphoma-new profiling, old tricks.
- Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.
- Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
- Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma.
- Autologous and Allogeneic Hematopoietic Cell Transplantation in Peripheral T/NK-cell Lymphomas: A Histology-Specific Review.
Clinical Trials
- A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)
- Phase 2, Single Arm, Open Label Study of Folotyn in Combination With Oral Leucovorin to Prevent or Reduce Mucositis in Patients With Hematological Malignancies
- A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
- T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
Treatments
- Lymphoma
- Leukemia
- Dermal Aesthetics
- Extra Corporeal Shockwave Therapy
Dr. Andrei R Shustov MD's Practice location
Dr. Andrei R Shustov MD's reviews
Write ReviewPatient Experience with Dr. Shustov
Recommended Articles
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- Survey Shows Lack of Blood Cancer Knowledge Among Americans
If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
Nearby Providers
- Dr. Nicole Kuderer M.D.825 Eastlake Ave E Seattle WA 98109
- Dr. Cynthia Chua MD1354 Aloha St Seattle WA 98109
- Dr. Sheldon Z Goldberg MD515 Minor Ave Seattle WA 98104
- Dr. Sharmila Ahmed MD1101 MADISON ST SEATTLE WA 98104
- Dr. Elena G Chiorean M.D.825 EASTLAKE AVE E SEATTLE WA 98109
- Dr. Vincent J Picozzi MD1100 9th Ave Seattle WA 98101